Development and internal validation of simplified predictive scoring (ICU-SEPSA score) for mortality in patients with

Taranee Sirichayanugul1, Chansinee Srisawat2, Chawin Thummakomut3

  • 1Division of Drug Information, Department of Pharmacy, Phrae Hospital, Phrae, Thailand.

Frontiers in Pharmacology
|September 19, 2022
PubMed

Insights

A new scoring tool, the ICU-SEPSA score, helps predict mortality risk in patients with multidrug-resistant (MDR) infections. This simplified screening method aids in identifying high-risk individuals for better patient outcomes.

Area of Science:

  • Infectious Diseases
  • Clinical Medicine
  • Public Health

Background:

  • Mortality from multidrug-resistant (MDR) pathogens presents a significant global healthcare challenge.
  • Current screening tools for predicting MDR infection mortality risk are limited.
  • There is a critical need for simplified methods to assess mortality risk in patients with MDR organisms.

Purpose of the Study:

  • To develop and validate a simplified screening tool for predicting mortality in patients with multidrug-resistant organism infections.
  • To identify key clinical risk factors associated with increased mortality in MDR infections.
  • To create a practical scoring system for clinical use.

Main Methods:

  • A retrospective cohort study was conducted at Phrae Hospital involving 504 patients with MDR infections.
  • Univariable and multivariable analyses identified significant risk factors for mortality.
  • Internal validation used a 1000-bootstrap procedure and receiver operating characteristic (AuROC) analysis to assess model performance.

Main Results:

  • The ICU-SEPSA score incorporates eight clinical risk factors: immunocompromised host, COPD, UTI, sepsis, endotracheal tube placement, pneumonia, septic shock, and recent antibiotic use.
  • The model demonstrated good calibration (p=0.50) and discrimination (AuROC 84.6%).
  • Positive likelihood ratios indicated significant predictive value for low (2.07) and high (12.35) risk scores.

Conclusions:

  • A simplified predictive scoring tool, the ICU-SEPSA score, was successfully developed to predict mortality in patients with MDR infections.
  • The tool shows good performance in discriminating between low and high mortality risk.
  • External validation is recommended before widespread clinical application due to the single-study design.